Hewlett, William A’s team published research in Nuclear Medicine and Biology in 1998-02-28 | 120570-05-0

Nuclear Medicine and Biology published new progress about 5-HT3 antagonists. 120570-05-0 belongs to class quinuclidine, and the molecular formula is C7H14N2, Category: quinuclidine.

Hewlett, William A.; Schmidt, Dennis E.; Mason, N. Scott; Trivedi, Bakula L.; Ebert, Michael H.; De Paulis, Tomas published the artcile< Synthesis and 5-HT3 receptor binding of 2- and 3-(halo)alkoxy substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands>, Category: quinuclidine, the main research area is benzamide alkoxyazabicyclooctylhalo preparation 5HT3 receptor binding; receptor 5HT3 binding alkoxyazabicyclooctylhalobenzamide radioligand; azabicyclooctaneazabicyclooctane alkoxyhalobenzamido preparation 5HT3 receptor binding.

In an effort to develop selective, high-affinity radioligands for the 5-HT3 receptor, a series of homologs of 5-chloro-2,3-dimethoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide (I, R = Cl) was prepared in which individual methoxy groups were replaced by ethoxy, 2-fluoroethoxy, allyloxy, propargyloxy, or (3-iodoallyl)oxy groups. Affinities for the 5-HT3 receptor were determined by displacement of the binding of [125I]MIZAC (I, R = 125I), a selective 5-HT3 receptor antagonist radioligand, in rat brain homogenates. The 3-substituted homologs were more potent than the lead compound, I (R = Cl). The homolog having the largest 3-substituent, i.e., (E)-(S)-II (R = OCH2CH:CHI, R1 = OMe) (THIZAC), had one of the highest affinities, Ki 0.08 nM. The 2-substituted homologs were equipotent with I (R = Cl), having Ki 0.2-0.3 nM, regardless of the size of the substituent. The corresponding iodoallyl derivative, (E)-(S)-II (R = OMe, R1 = OCH2CH:CHI) (LIZAC), displayed a Ki of 0.29 nM. Saturation binding of [125I]-LIZAC gave a KD of 0.31 ± 0.04 nM and a Bmax of 2.36 ± 0.10 fmol/mg of entorhinal cortex. In vivo biodistribution of [125I]-LIZAC in the rat brain showed increased accumulation in hippocampus relative to that in cerebellum. Both the high-affinity ligands [125I]-THIZAC and [125I]-LIZAC are potentially useful radioligands for studying the 5-HT3 receptor.

Nuclear Medicine and Biology published new progress about 5-HT3 antagonists. 120570-05-0 belongs to class quinuclidine, and the molecular formula is C7H14N2, Category: quinuclidine.

Referemce:
Quinuclidine – Wikipedia,
Quinuclidine | C7H13N | ChemSpider